Read More Pharma Industry News Curis doses first patient in CA-4948 phase 1 clinical trial in AML and MDS CA-4948 phase 1 clinical trial : US biotech company Curis said that it has dosed the first patient… bypharmanewsdailyJuly 7, 2020